Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sino Biopharmaceutical Ltd (OP: SBHMY )

9.650 +1.650 (+20.63%)
Streaming Delayed Price Updated: 2:28 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,263
Open 9.367
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 8.000
Today's Range 9.360 - 9.650
52wk Range 6.685 - 9.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
From Sino Biopharmaceutical Limited
Via ACN Newswire
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies... 
Via Talk Markets

Performance

YTD
+31.56%
+31.56%
1 Month
N/A
N/A
3 Month
+33.10%
+33.10%
6 Month
+44.25%
+44.25%
1 Year
+44.03%
+44.03%

More News

Read More
Week In Review: Betta Pharma Enters $392 Million Deal For C4 Therapeutics’ NSCLC Drug
Via Talk Markets
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
Via Talk Markets
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.